Join
Live feed
·
INSIDERFilingvia Quantisnow
Agios Pharmaceuticals Inc. logo

Chief Financial Officer Jones Cecilia converted options into 16,969 shares and sold $145,814 worth of shares (5,035 units at $28.96), increasing direct ownership by 32% to 49,328 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGIO (Agios Pharmaceuticals Inc.) and more on Quantisnow.